|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
3.950 +0.090 (+2.332%) Ranking Overview
Ranking based on 10 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
10
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 19.13 RMB (cts) | |
| Net Profit | 3,499.83 RMB (MIL) | DPS | 6.53 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 3,108.50 | 16.89 | 5.17 | -- | 3,823.00 | 2,373.00 |
| 2026 | 3,468.50 | 18.42 | 5.87 | -- | 4,201.00 | 2,816.00 |
| 2027 | 3,864.00 | 20.50 | 7.60 | -- | 4,019.00 | 3,255.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 3,220.00 | 17.60 | 593.50 | CITIGROUP | Buy | 6.20 | 21/03/2025 | |
| 2025 | 3,125.00 | 16.78 | -- | NOMURA | Buy | 5.52 | 20/03/2025 | |
| 2025 | 2,963.00 | 16.00 | 5.14 | UBS | Buy | 5.00 | 20/11/2024 | |
| 2025 | 2,971.00 | 15.50 | -- | BOCOM | Buy | 4.80 | 21/03/2025 | |
| 2025 | 3,264.00 | 17.00 | -- | MORGAN STANLEY | Overweight | 4.60 | 20/03/2025 | |
| 2025 | 3,276.00 | 17.40 | 5.20 | BOCI | Buy | 4.50 | 21/03/2025 | |
| 2025 | 2,373.00 | 12.60 | 4.40 | BANK OF AMERICA | Buy | 4.40 | 21/03/2025 | |
| 2025 | 3,092.00 | 17.00 | 7.00 | CCBI | OutPerform | 4.40 | 20/03/2025 | |
| 2025 | 3,823.00 | 20.00 | 7.00 | CICC | OutPerform | 4.20 | 21/03/2025 | |
| 2025 | 2,803.00 | 15.00 | 5.00 | HSBC | Buy | 3.80 | 27/01/2025 | |
| 2026 | 3,318.00 | 18.10 | 611.50 | CITIGROUP | -- | -- | 21/03/2025 | |
| 2026 | 3,450.00 | 18.53 | -- | NOMURA | -- | -- | 20/03/2025 | |
| 2026 | 3,247.00 | 17.00 | 5.74 | UBS | -- | -- | 20/11/2024 | |
| 2026 | 3,512.00 | 18.30 | -- | BOCOM | -- | -- | 21/03/2025 | |
| 2026 | 3,726.00 | 20.00 | -- | MORGAN STANLEY | -- | -- | 20/03/2025 | |
| 2026 | 3,553.00 | 18.90 | 5.70 | BOCI | -- | -- | 21/03/2025 | |
| 2026 | 2,816.00 | 15.00 | 5.30 | BANK OF AMERICA | -- | -- | 21/03/2025 | |
| 2026 | 3,487.00 | 19.00 | 8.00 | CCBI | -- | -- | 20/03/2025 | |
| 2026 | 4,201.00 | 22.00 | 8.00 | CICC | -- | -- | 21/03/2025 | |
| 2026 | 2,985.00 | 16.00 | 6.00 | HSBC | -- | -- | 27/01/2025 | |
| 2027 | 3,444.00 | 18.80 | 634.80 | CITIGROUP | -- | -- | 21/03/2025 | |
| 2027 | 4,019.00 | 21.00 | -- | BOCOM | -- | -- | 21/03/2025 | |
| 2027 | 3,864.00 | 20.50 | 6.20 | BOCI | -- | -- | 21/03/2025 | |
| 2027 | 3,929.00 | 21.00 | 9.00 | CCBI | -- | -- | 20/03/2025 | |
| 2027 | 3,255.00 | 17.30 | 6.10 | BANK OF AMERICA | -- | -- | 21/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 02/04/2025 17:54 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,499,834 |
| %Change | 50.083% |
| EPS / (LPS) | RMB 0.191 |
| NBV Per Share (¥) | RMB 1.701 |